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Abstract Ku, a heterodimer of 70- and 80-kDa subunits, plays a
general role in the metabolism of DNA ends in eukaryotic cells,
including double-strand DNA break repair, V(D)J recombina-
tion, and maintenance of telomeres. We have utilized the yeast
two-hybrid system to identify Ku70-interacting proteins other
than Ku80. Two reactive clones were found to encode the
dimerization domain of TRF2, a mammalian telomeric protein
that binds to duplex TTAGGG repeats at chromosome ends.
This interaction was confirmed using bacterial fusion proteins
and co-immunoprecipitations from eukaryotic cells overexpres-
sing TRF2. The transfected TFR2 colocalized with
Ku70. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Ku was originally identi¢ed as a major autoantigen in pa-
tients with autoimmune diseases such as scleroderma-poly-
myositis [1]. Ku is a heterodimer of 70- and 80-kDa subunits
[2,3], and binds to DNA ends, nicks, or single- to double-
strand transition [2,3], and serves as a DNA binding compo-
nent of a DNA-dependent protein kinase (DNA-PK) that
phosphorylates certain chromatin-bound proteins in vitro
[4,5]. Both Ku and the catalytic subunit of DNA-PK have
been shown to be crucial for double-strand-break DNA repair
and V(D)J recombination [6^8].
It has been suggested that Ku played an important role in
the regulation and maintenance of telomeres as well. In Sac-
charomyces cerevisiae, mutants of either human Ku70 or
Ku80 homologues, YKU70/HDF1 and YKU80/HDF2, were
shown to have abnormally short telomeres [9,10], and dis-
rupted subnuclear organization of telomeres [11]. Mutations
in either Ku subunit led to enhanced instability of telomeres
by increasing their sensitivity to either degradation or recom-
bination reactions [12]. Ku has been shown to be an integral
component of the telomere in yeast [13] and to bind human
telomeric DNA in vitro [14]. Ku was also shown to be asso-
ciated with the telomere in mammalian cells [15].
Ku is a relatively abundant protein, approximately 5U105
molecules per nucleus [16]. Recently, we have shown that Ku
was present in the nuclear matrix as well as in the soluble
fractions of the human nucleus [17]. In the nuclear matrix,
Ku70 appeared to be present in larger amounts than Ku80
[17]. Thus, it appeared that Ku70 might bind other proteins to
perform diverse biological functions at least in certain cellular
compartments. This possibility prompted us to look for addi-
tional interacting proteins of Ku70.
A number of attempts have been made to identify proteins
that interact with Ku70 using the yeast two-hybrid system. It
was shown that Hdf1p, a yeast homologue of Ku70, inter-
acted with Sir4p, which was required for telomere position
e¡ect [18]. In addition, human Ku70 was identi¢ed to be an
interacting protein of hGCN5 acetyltransferase [19], oncopro-
tein p95vav [20], and apolipoprotein J [21].
In our yeast two-hybrid system, two reactive clones were
found to encode a telomere-speci¢c DNA binding protein,
TRF2. TRF2 is one of the telomere-speci¢c DNA binding
proteins in mammals [22,23], and is known to protect the
telomere from end-to-end fusion [24]. Here we report that
the Leu-Ser repeat domain of Ku70 can interact with TRF2.
Ku70 may have a role in the regulation and maintenance of
telomeres through the interaction with TRF2.
2. Materials and methods
2.1. Yeast two-hybrid screening of human cDNA library
The full-length human Ku70 cDNA was a kind gift from Dr. W.H.
Reeves [25]. For the yeast two-hybrid analysis, we employed the sys-
tem developed by the Brent laboratory [26]. The bait, LexA-Ku70/
186, contained partial cDNA corresponding to amino acid residues
200^385 (186 aa) of Ku70. The plasmid was introduced into yeast
S. cerevisiae strain EGY48 [MATa, his3, trp1, ura3-52, leu2: :pLeu2-
LexAop6/pSH18-34 (LexAop-lacZ reporter)] by a modi¢ed lithium
acetate method. The yeast transformants carrying the bait were used
to screen a HeLa cDNA library as described previously [26]. The bait
did not have any intrinsic activity of transcriptional activation for the
reporters. The bait^prey interchange experiments were carried out for
all positive interactions.
As control baits, LexA-Ku70/139 and LexA-DDX3 were used to
determine whether the isolated plasmids showed speci¢city to Lex-
Ku70/186 for interaction with the reporter genes. LexA-Ku70/139
contained amino acid residues 471^609 (139 aa) of Ku70, which en-
compassed another repeat of leucine at the C-terminus [25]. LexA-
DDX3 contained a full-length human DDX3 in which a leucine repeat
was also included [27].
To further identify the interaction domains in Ku70, LexA-Ku70/
119, which contained a partial cDNA corresponding to amino acid
residues 267^385 (119 aa), was tested similarly. To delineate interact-
ing domains of the selected TRF2/B22, four deletion constructs ex-
pressing amino acid residues 38^140, 49^197, 120^230, and 180^247 of
TRF2 were generated. The full-length TRF2 cDNA clone phTRF216-
1 was a kind gift from Dr. T. de Lange [22].
2.2. Expression of recombinant proteins in Escherichia coli
In-frame fusion of the recombinant full-length Ku70 gene was con-
structed with the pET28 vector (Novagen) for bacterial expression as
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an amino-terminal (His)6-tagged protein. When the recombinant full-
length Ku70 was expressed in bacteria, it was degraded with its N-
terminal portion cleaved. To construct a plasmid expressing the N-
terminal deletion of the Ku70 gene product, pET28a/Ku70/200-609, a
fragment of 1234 bp encompassing amino acids 200^609 was obtained
by PCR using a sense primer (5P-CCTTGACTTGATGCACCTGA-
3P) and an antisense primer (5P-TCAGTCCTGGAAGTGCTTGG-3P).
The PCR product was ¢rst cloned into vector pCR2.1 (Invitrogen),
then a 1250-bp EcoRI fragment from pCR2.1-Ku70/410 was cloned
into the EcoRI site of pET28a. Ku70vN recombinant protein, which
expressed amino acid residues 200^609 and 38 additional amino acids,
was partly soluble.
The (His)6-tagged recombinant full-length TRF2 protein was not
expressed properly in the bacteria either. To construct a plasmid ex-
pressing TRF2vM, which was devoid of the Myb-like C-terminus [24],
the cDNA encompassing amino acids 1^442 was obtained by PCR
with the full-length TRF2 cDNA clone phTRF216-1 using a sense
primer (5P-CTGAATTCATGGCGGGAGGAGGC) and an antisense
primer (5P-GCAAGCTTCAGGTTGTACTGTCTTC-3P). The PCR
products were digested with EcoRI/HindIII and cloned into the
EcoRI/HindIII sites of pET28a. TRF2vM fusion protein was also
partly soluble.
To construct a plasmid expressing TRF2B22, TRF2 insert was gen-
erated by liberation from the pJG4-5 prey B22 by EcoRI/XhoI diges-
tion followed by cloning into the EcoRI/XhoI sites of pET28a. The
product expressed in bacteria was poorly soluble, and was recovered
partly by electroelution according to the manufacturer’s instruction
(Bio-Rad).
2.3. In vitro protein interaction
For in vitro binding assays, 10 Wg of puri¢ed recombinant TRF2B22
was incubated with 20 Wg of Ku70vN in the reaction bu¡er (20 mM
HEPES^KOH pH 7.9, 100 mM KCl, 0.2 mM EDTA, 0.2 mM EGTA,
0.5 mM dithiothreitol (DTT), 0.5 mM phenylmethylsulfonyl £uoride
(PMSF), 0.1% NP-40, and 0.1% Triton X-100) for 1 h at 4‡C. Then,
immunoprecipitation was performed with monoclonal anti-Ku70 anti-
body NMB1 [17]. After application of goat anti-mouse Ig second
antibody, immune complexes were precipitated with protein A-Se-
pharose beads. The precipitates were resolved in 10% SDS^PAGE
sample bu¡er, electrotransferred to nitrocellulose paper, and immuno-
blotted with anti-T7WTag antibody. The antigen^antibody complexes
were visualized using a NBT/BCIP color reaction (Boehringer-Mann-
heim) or enhanced chemiluminescence (ECL detection system, Amer-
sham).
To see the e¡ect of TRF2 binding on the association of Ku70 and
Ku80, an excessive amount (100 Wg) of puri¢ed TRF2vM was added to
the extracts of 1U105 HeLa cells. HeLa cells were extracted in 200 Wl
extraction bu¡er (20 mM HEPES^KOH pH 7.9, 420 mM KCl, 25%
glycerol, 0.1 mM EDTA, 5 mM MgCl2, 1 mM DTT, 0.5 mM PMSF,
and 0.2% NP-40) for 30 min and centrifuged for 10 min at 14 000Ug.
The supernatant was dialyzed for 5 h against 100 ml of reaction
bu¡er.
2.4. In vivo interaction in cells with transient transfection of TRF2
COS cells were maintained in Dulbecco’s modi¢ed Eagle’s medium
supplemented with 10% (v/v) fetal bovine serum, 100 U/ml penicillin
and 100 U/ml streptomycin at 37‡C in 5% CO2. The TRF2B22 cDNA
with T7WTag was inserted into pcDNA3 (Invitrogen). COS cells were
transfected with 3 Wg of plasmid DNA/60-mm dish using Lipofect-
Amine Plus1 reagent (Gibco BRL). At 24 h after transfection, the cell
lysates were prepared and analyzed by immunoprecipitation assays.
The whole cell extracts were incubated with monoclonal anti-Ku70,
anti-Ku80 [17], and anti-T7WTag antibodies (Novagen) for 2 h at 4‡C,
followed by the immunoprecipitation procedure as described above.
As a negative control, preimmune mouse serum was incubated with
the cell extracts.
2.5. Immuno£uorescence microscopy
The TRF2vM cDNA with T7WTag was inserted into pcDNA3. It
was chosen because the prey TRF2B22 lacked a nuclear localization
signal. COS cells were plated on coverslips and transfected with 1 Wg
of plasmid DNA/35-mm dish as described above. At 24 h after trans-
fection, cells were ¢xed in cold methanol at 320‡C. As primary anti-
bodies, polyclonal anti-TRF2 antibody and a monoclonal anti-Ku70
antibody, NMB1, were applied. The a⁄nity-puri¢ed anti-TRF2 anti-
body was obtained from antisera of a rabbit, which was immunized
using the gel-puri¢ed TRF2vM recombinant protein. Alternatively,
anti-T7WTag antibody, and/or polyclonal anti-Ku70 antibodies (Santa
Cruz Biotechnology) were applied. After the double immunostaining
using rhodamine-conjugated anti-rabbit or anti-goat IgG secondary
antibody and £uorescein isothiocyanate (FITC)-conjugated anti-
mouse IgG secondary antibody (Zymed), cells were viewed using a
confocal laser microscope (Zeiss LSM510). As controls, cells were
stained with primary or secondary antibody alone. Control slides
did not display signi¢cant £uorescence in any case.
3. Results and discussion
3.1. Yeast two-hybrid screening
The search for Ku binding proteins using the yeast two-
hybrid system has been limited because of the predominant
interaction between the two subunits; when full-length cDNA
of human Ku70 or Ku80 bait was used, only the expected
counterpart, i.e. Ku80 or Ku70, was reported to be detected
[28,29]. In an attempt to identify additional Ku70 binding
partners, we decided to use the bait of Ku70 partial cDNA
in our yeast two-hybrid screening.
Fig. 1. The yeast two-hybrid system. Domains of Ku70 are shown at the top left. Bars below the lines designate inserts of three baits used for
the yeast two-hybrid analysis. Domains of TRF2 are shown in the middle; NLS, nuclear localization signal; Myb, Myb-like DNA binding site.
Bars below the lines represent the retrieved prey TRF2/B22 and its truncated forms.
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The bait, LexA-Ku70/186, contained Ku70 partial cDNA
corresponding to amino acid residues 200^385, which did not
overlap signi¢cantly with the published Ku80 binding sites
(Fig. 1) [30^32]. In the area, a periodic repeat of leucine
and serine (aa 215^243) in every seventh position was included
(Fig. 1); thus, it was compatible with the leucine zipper struc-
ture [33] except that it was not a repeat of leucine alone. The
Leu-Ser repeat abutted a strongly basic region, and displayed
signi¢cant sequence similarity to a region of v-myc and c-myc
proteins [30].
Approximately 3U105 independent transformants were
pooled and re-spread on the selection medium (Ura3, His3,
Trp3, Leu3) containing 2% galactose to induce the expression
of cDNAs. In the selection medium, a total of 72 colonies
showed galactose dependence. The plasmids were extracted
by yeast miniprep, the cDNAs were PCR-ampli¢ed with prim-
ers derived from vector pJG4-5, followed by sequence deter-
mination.
DNA sequencing and database searches revealed that the
nucleotide sequence of clones B22 and B46 encoded the N-
terminal portion of human TRF2 encompassing amino acid
residues 38^230 [23,24]. The clones turned out to be identical
in DNA sequence as well as in size. This region overlapped
with the dimerization site of TRF2 (aa 46^245) [23,24] : the
inserts had seven additional amino acid residues at the N-
terminus and lacked 15 amino acid residues at the C-terminus
of the dimerization site.
It has been proposed that leucine zipper proteins might
interact among themselves through the motifs [33]. To further
con¢rm the speci¢city of the interaction, two additional baits
containing similar leucine zipper-like motifs were tested in the
two-hybrid system: LexA-Ku70/139 (aa 471^609) and LexA-
DDX3. They included the leucine zipper-like domain at the C-
terminus of Ku70 [25] and the leucine zipper motif of putative
RNA helicase DDX3 [27], respectively. As shown in Fig. 1,
TRF2 did not interact with either of them. The results indi-
cated that the association of Ku70/TRF2 was not mediated by
non-speci¢c interaction of the Leu-Ser domain of Ku70.
Fig. 2. In vitro interaction of recombinant TRF2 and Ku. Recombi-
nant Ku70vN and TRF2B22 proteins were incubated in the reaction
bu¡er at 4‡C for 1 h, and immunoprecipitated with anti-Ku70
monoclonal antibody NMB1. As shown in lane 1, the immunoblot-
ting with anti-T7WTag antibody showed both Ku70vN and TRF2B22
indicating co-immunoprecipitation of TRF2B22 and Ku70vN in vitro.
Lanes 2 and 3 show puri¢ed Ku70vN and TRF2B22 inputs for refer-
ence, respectively.
Fig. 3. In vitro interaction of recombinant TRF2vM with native Ku. a: Coomassie-stained gel of immunoprecipitates. An excessive amount of
puri¢ed recombinant TRF2vM protein was incubated with HeLa cell extracts, and Ku70 was immunoprecipitated with a monoclonal anti-Ku70
antibody and a goat anti-mouse IgG second antibody (lane 1). As a control, the immunoprecipitation was performed under the same condition
without TRF2vM (lane 2). In lanes 1 and 2, the IgG heavy chains consisted of both goat (larger) and mouse (smaller) immunoglobulin, while
only mouse immunoglobulin heavy chain was present in the control lane 3. In lanes 1 and 2, Ku80 was co-precipitated with Ku70. b: Immuno-
blotting with anti-TRF2 antibody, the same precipitate as in a. TRF2vM, estimated molecular weight 55 kDa, was detected between the goat
and mouse heavy chains (lane 1). Lane 4 shows the input TRF2vM. c: Immunoblotting with polyclonal anti-Ku70 antisera, the same precipi-
tate. The estimated amount of Ku70 was similar between lanes 1 and 2. d: Immunoblotting with polyclonal anti-Ku80 antisera, the same pre-
cipitate. Ku80 was co-immunoprecipitated with Ku70. The estimated amount of Ku80 was similar between lanes 1 and 2.
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3.2. Binding domains of Ku70 and TRF2
To narrow down the domain of Ku70 responsible for the
interaction with TRF2 further, a truncated bait, LexA-Ku70/
119 (aa 267^385) lacking the Leu-Ser repeat was constructed
and introduced into the EGY48 strain. As shown in Fig. 1,
this deletion completely abolished the interaction with the
TRF2. Therefore, the Leu-Ser repeat appeared to be essential
for the interaction with TRF2. Our data suggest that the Leu-
Ser repeat may be a site through which Ku70 interacts with
protein(s) other than Ku80. However, it does not appear to be
the only interaction site preserved for the purpose. It has been
shown that Ku70 interacts with the oncogene product p95vav
through the C-terminus [19].
The preys contained a region which largely overlapped with
the dimerization site of TRF2 (aa 46^245). To delineate the
domain of TRF2 responsible for the interaction further, we
constructed four TRF2 deletion mutants which represented
peptides of aa 38^140, 49^197, 120^230, and 180^247 (Fig.
1). None of the truncated preys interacted with Ku70, indicat-
ing that the entire region of TRF2B22 (aa 38^230) was re-
quired for the interaction.
3.3. In vitro interaction between recombinant Ku70 and TRF2
To validate the results obtained with the yeast two-hybrid
system, the interaction of recombinant Ku70vN with TRF2B22
proteins was examined by immunoprecipitation in vitro. Re-
combinant Ku70vN and TRF2B22 were incubated in the reac-
tion bu¡er at 4‡C for 1 h. Then, Ku70 was immunoprecipi-
tated with monoclonal antibody NMB1 the epitope of which
was at the C-terminus of Ku70. As shown in Fig. 2, lane 1,
TRF2B22 was co-immunoprecipitated with Ku70vN indicating
binding in vitro. The puri¢ed Ku70vN and TRF2B22 are
shown in separate lanes (Fig. 2, lanes 2 and 3).
We further examined whether the binding of recombinant
TRF2 would interfere with the association of native Ku70 and
Ku80. HeLa cell extracts were incubated with excessive
amounts of puri¢ed recombinant TRF2vM, and Ku70 was
immunoprecipitated from the extracts using the monoclonal
antibody NMB1 (Fig. 3a, lane 1: Coomassie blue-stained gel).
For negative controls, the same immunoprecipitation without
additional TRF2vM (lane 2) and immunoprecipitation with
normal mouse serum (lane 3) were included. As was shown
with TRF2B22, TRF2vM also co-immunoprecipitated with
Ku70 (Fig. 3b, lane 1). The failure to detect endogenous
TRF by immunoblotting could be due to its relatively scant
amount in the extract. When the same precipitates were im-
munoblotted with anti-Ku70 antibody NMB1, the amount of
Ku70 was similar to that in the negative control without
TRF2vM (Fig. 3c, lanes 1 and 2). Ku80 was also detected
similarly regardless of the addition of excessive TRF2vM
(Fig. 3d, lanes 1 and 2). Thus, it appeared that the presence
of excessive TRF2 did not interfere with the association of
Ku70 and Ku80 in vitro.
3.4. In vivo interaction and co-localization of Ku70 and
transfected TRF2
To verify the interaction in vivo, we performed a series of
co-immunoprecipitation experiments using COS cells which
overexpressed TRF2B22 fused to a T7WTag. As was expected,
Ku70 and Ku80 co-precipitated by either anti-Ku70 or anti-
Ku80 antibodies (Fig. 4a,b, lanes 2 and 3). When TRF2B22
was immunoprecipitated using anti-T7WTag antibody, Ku70
was co-precipitated (Fig. 4a, lane 4) whereas Ku80 was not
(Fig. 4b, lane 4). The results suggested that TRF2B22 inter-
acted with Ku70 but not with Ku80 directly in vivo.
Fig. 4. In vivo interaction of transfected TRF2 and cellular Ku.
a: The extracts of COS cells transfected with T7-tagged TRF2B22
were immunoprecipitated with anti-Ku70, anti-Ku80, and anti-
T7WTag antibodies, respectively. The immunoblotting was done with
a monoclonal anti-Ku70 antibody. Ku70 was co-immunoprecipitated
with Ku80 and TRF2B22, respectively (lanes 3 and 4). COS cells
without transfection were used as negative control (lane 5). b: Im-
munoblotting with anti-Ku80 antibody, the same precipitates. Ku80
was not co-immunoprecipitated with TRF2B22 (lane 4).
Fig. 5. Double immuno£uorescence microscopy of Ku70 and trans-
fected TRF2. COS cells were transfected with pcDNA3/TRF2vM. At
24 h after transfection, cells were ¢xed in cold methanol and then
double immunostaining was done using monoclonal anti-T7WTag
antibody and polyclonal anti-Ku70 antibody. Slides were examined
using Carl Zeiss confocal microscope LSM510. Both transfected
TRF2vM (a, rhodamine-labeled) and native Ku70 (b, FITC-labeled)
are distributed in a di¡use reticular pattern with intermixed un-
stained areas. A merged image (c) shows that they are largely co-lo-
calized.
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To determine whether Ku70 and TRF2 co-localized in the
nucleus, COS cells were transiently transfected with a mam-
malian expression plasmid encoding T7-tagged TRF2vM.
Upon immunostaining with either polyclonal anti-TRF2 anti-
body or monoclonal anti-T7WTag antibody, about 5% of cells
displayed expression of transfected TRF2vM in a di¡use, re-
ticular pattern (Fig. 5a). Ku70 also displayed a similar immu-
no£uorescence pattern (Fig. 5b) as was described previously
[17]. The Ku70 staining pattern was similar between the cells
with or without TRF2vM expression. With double immuno-
£uorescence staining, it was shown that the transfected
TRF2vM mostly co-localized with native Ku70 (Fig. 5c).
Our results suggest that Ku and TRF2, which are both
essential for the maintenance of telomeres [9^12,24], form a
functional complex in vivo. Ku has been shown to play a
crucial role in DNA double-strand-break repair for any par-
ticular nucleotide sequence or end con¢guration [6^8]. Since
telomeres contain DNA double-strand breaks essentially, the
‘non-speci¢c’ repair function of Ku would have to be con-
trolled in a way that end-to-end fusion of chromosomes is
prevented. Considering that Ku interacts with other proteins
such as Sir at the telomere [18], the Ku function at the telo-
mere appears to be regulated in a complicated network of
protein-to-protein interactions in which TRF2 would certainly
be a key factor.
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